Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Other Working Capital Changes: 2010-2021

Historic Other Working Capital Changes for Neurocrine Biosciences (NBIX) over the last 10 years, with Dec 2021 value amounting to -$12.5 million.

  • Neurocrine Biosciences' Other Working Capital Changes rose 60.44% to -$12.5 million in Q4 2021 from the same period last year, while for Dec 2021 it was $9.2 million, marking a year-over-year increase of 148.65%. This contributed to the annual value of $24.5 million for FY2024, which is 151.26% up from last year.
  • As of Q4 2021, Neurocrine Biosciences' Other Working Capital Changes stood at -$12.5 million, which was down 177.64% from $16.1 million recorded in Q3 2021.
  • Neurocrine Biosciences' Other Working Capital Changes' 5-year high stood at $31.2 million during Q3 2020, with a 5-year trough of -$31.6 million in Q4 2020.
  • Moreover, its 3-year median value for Other Working Capital Changes was $1.2 million (2019), whereas its average is $975,000.
  • Its Other Working Capital Changes has fluctuated over the past 5 years, first plummeted by 6,597.67% in 2017, then surged by 3,500.00% in 2020.
  • Neurocrine Biosciences' Other Working Capital Changes (Quarterly) stood at -$5.8 million in 2017, then spiked by 70.24% to -$1.7 million in 2018, then soared by 753.44% to $11.2 million in 2019, then slumped by 382.14% to -$31.6 million in 2020, then skyrocketed by 60.44% to -$12.5 million in 2021.
  • Its last three reported values are -$12.5 million in Q4 2021, $16.1 million for Q3 2021, and $3.0 million during Q2 2021.